Know Cancer

or
forgot password

The Pilot Palliative ARNP (Advanced Registered Nurse Practitioner) Liaison Program (The PAL Program): Improving Communication Between Patients, Oncologists, and Hospice, Promoting Timely Hospice Referrals and Bringing Education and Research Efforts to Hospice and Palliative Care


N/A
18 Years
N/A
Open (Enrolling)
Both
Hematopoietic/Lymphoid Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Thank you

Trial Information

The Pilot Palliative ARNP (Advanced Registered Nurse Practitioner) Liaison Program (The PAL Program): Improving Communication Between Patients, Oncologists, and Hospice, Promoting Timely Hospice Referrals and Bringing Education and Research Efforts to Hospice and Palliative Care


OBJECTIVES:

Primary

- To assess the effect of the palliative advanced registered nurse practitioner liaison
program (PAL) on length of patient's enrollment in hospice care.

Secondary

- To evaluate the impact of the PAL program on patient's knowledge about hospice
services.

- To evaluate the impact of the PAL program on patient and family or caregiver's
psychological stress during palliative treatments.

OUTLINE: Patients are randomized to 1 of 2 arms.

- Arm I (advanced registered nurse practitioner [ARNP] intervention): Patients and their
families or caregiver receive information from an ARNP about terminal cancer, resources
available for supportive care, and the benefits of palliative care. After transition to
hospice, patients receive pain and palliative medicine, psychology, social services,
chaplaincy, and patient support group intervention arranged by the ARNP. Patients
complete the Patient Questionnaire about overall quality of life and mental, emotional,
and physical well being at baseline and at 3 weeks after intervention or at time of
enrollment in hospice. Patients and their families or caregivers are contacted by the
ARNP weekly.

- Arm II (no ARNP intervention): Patients and their families or caregivers complete the
same Patient Questionnaire, administered by a clinical research assistant (CRA), as in
Arm I. Patients and their families or caregivers receive no ARNP intervention. After
transition to hospice, patients receive routine hospice care.

Patients participate in this study for a duration of 21 days while in hospice care. At the
completion of the study, patients in both arms complete questionnaires about pain
management, social, emotional, and spiritual and mental well-being. Patients' families or
caregivers complete the Caregiver Questionnaire and the Hospice Family Satisfaction Survey 3
weeks after patient's death.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of terminal metastatic cancer

- Patient at Mayo Clinic in Jacksonville, Florida

- Strong candidate for hospice care

- Entering or planning to enter Community Hospice of Northeast Florida

- Willing to undergo visits by an Advanced Registered Nurse Practitioner (ARNP)
after hospice enrollment

PATIENT CHARACTERISTICS:

- Willing to participate in 2 palliative care consultations with an ARNP prior to
hospice enrollment

- Life expectancy < 12 months

- Able to complete questionnaires with or without assistance

- Has a primary caregiver with an identified relationship to the patient

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Type of Study:

Interventional

Study Design:

N/A

Outcome Measure:

Increased length of enrollment time in hospice care

Safety Issue:

No

Principal Investigator

Gerardo Colon-Otero, M.D.

Investigator Role:

Study Chair

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Federal Government

Study ID:

CDR0000615562

NCT ID:

NCT00896792

Start Date:

October 2008

Completion Date:

Related Keywords:

  • Hematopoietic/Lymphoid Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • unspecified adult solid tumor, protocol specific
  • hematopoietic/lymphoid cancer

Name

Location

Mayo Clinic in JacksonvilleJacksonville, Florida  32224